Linking In With Advice and Supports for Men Impacted by Metastatic Cancer (NCT05946993) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
Ireland72 participantsStarted 2023-05-08
Plain-language summary
To evaluate the feasibility of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary malignancies.
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Men aged ≥ 18 years of age at the time of study enrolment.
. Willing to participate in a 12-week intervention programme and follow up procedures as outlined in the Schedule of Activities section.
. ECOG performance status 0-2.
. Recovery to CTCAE Grade ≤2 adverse events from all prior therapies, or adequately recovered adverse events whereby, whereby the PI feels they will not impact the participants ability to complete the 12-week intervention.
. Disease-specific inclusion criteria:
. Participation in other translational or interventional clinical trials is permitted provided the above disease-specific inclusion criteria are met.
. Signed consent form by the participant or a legally authorized representative (LAR).
Exclusion criteria
. Persons who, in the opinion of the researcher or supervising clinician, are unable to cooperate adequately with the study protocol, for example those receiving systemic therapy for a concurrent cancer diagnosis, those with organ system dysfunction which would impact their safe participation in the study, or other uncontrolled medical illness that would impact their safe participation in the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility as assessed by a purposefully designed feasibility questionnaire
Timeframe: At week 12
2
Feasibility as assessed by a purposefully designed feasibility questionnaire
Timeframe: At 6-month post intervention timepoint
3
The acceptability of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary cancer
Timeframe: At week 12
4
The acceptability of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary cancer
Timeframe: At the 6-month post intervention timepoint